Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Skeletal muscle Mass
100%
Heterozygous Mice
100%
Hindlimb Immobilization
100%
Delayed Recovery
100%
Protein Synthesis
75%
Regrowth
50%
Muscle Mass
37%
Wild Mice
37%
Proteasome Activity
37%
Recovery Period
25%
Atrophy
25%
Between-group
12%
Gastrocnemius
12%
Inflammatory Cytokine Response
12%
Inflammatory Response
12%
Protein Degradation
12%
Leucine
12%
Immobilization
12%
I to
12%
Muscle Protein
12%
Plateaued
12%
Basal Values
12%
MuRF1
12%
CD45
12%
Muscle Mass Loss
12%
Atrogin-1
12%
Medicine and Dentistry
Mammalian Target of Rapamycin
100%
Hindlimb
100%
Skeletal Muscle
100%
Protein Synthesis
75%
Proteasome
37%
Protein Degradation
12%
Serositis
12%
Tumor Necrosis Factor
12%
Cytokine Response
12%
Inflammatory Cytokine
12%
Gastrocnemius
12%
Leucine
12%
Contralateral
12%
Atrogin 1
12%
Messenger RNA
12%
Biochemistry, Genetics and Molecular Biology
Skeletal Muscle
100%
Mammalian Target of Rapamycin
100%
Protein Biosynthesis
75%
Proteasome
37%
Wild Type Mouse
37%
Wild Type
12%
Tumor Necrosis Factor
12%
Protein Catabolism
12%
Leucine
12%
Cytokine Response
12%
Inflammatory Cytokine
12%
Messenger RNA
12%
Immunology and Microbiology
Skeletal Muscle
100%
Muscle
100%
Protein Synthesis
54%
Proteasome
27%
Wild Type Mouse
27%
Wild Type
9%
Tumor Necrosis Factor
9%
Protein Degradation
9%
Inflammatory Cytokine
9%
Inflammation Response
9%
Cytokine Response
9%
Leucine
9%